You are using an older browser version. Please use a supported version for the best MSN experience.

Gilead's pricing for coronavirus drug remdesivir was unexpectedly 'more expensive': Professor

Gilead Sciences Inc's pricing for the coronavirus drug remdesivir was "more expensive" than many people had expected, says Richard Martinello of the Yale-NUS Medical School. He adds that he hopes to see more market competition emerge to "drive the costs down for everybody."

Most Recent



image beaconimage beaconimage beacon